Valeant Pharmaceuticals International Inc. is in talks to sell its Salix stomach-drug business to Japanese pharmaceutical company Takeda Pharmaceutical Co., according to people familiar with the matter.
The deal could potentially raise as much as $10 billion for the indebted drugmaker, the people said, asking not to be identified because the discussions are private.
There is no guarantee that the discussions will lead to a deal, they said.
Valeant is working with investment bank Morgan Stanley on the sale, they added. News of the talks was first reported by the Wall Street Journal.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Oracle's Larry Ellison says planned Nashville campus will be company's 'world headquarters'
Oracle Corp.'s planned campus in Nashville, Tennessee, will serve as the business software giant's world headquarters, placing it in a city that's a center for the U.S. health care industry, CEO Larry Ellison said.
Business
Biden picks up another big union endorsement, this one from building trades workers
President Joe Biden picked up the endorsement of North America's Building Trades Unions at a Wednesday event where the president and his allies set out to dismantle Republican Donald Trump's reputation as a successful real estate developer.
Business
About 1 in 4 US adults over 50 say they expect to never retire, an AARP study finds
About one-quarter of U.S. adults over age 50 say they expect to never retire and 70% are concerned about prices rising faster than their income, an AARP survey finds.
Business
Dairy cattle must be tested for bird flu before moving between states, agriculture officials say
Dairy cattle moving between states must be tested for the bird flu virus, U.S. agriculture officials said Wednesday as they try to track and control the growing outbreak.
Business
Boeing's financial woes continue, while families of crash victims urge US to prosecute the company
Boeing said Wednesday that it lost $355 million on falling revenue in the first quarter, another sign of the crisis gripping the aircraft manufacturer as it faces increasing scrutiny over the safety of its planes and accusations of shoddy work from a growing number of whistleblowers.
